Treatment of Clostridium difficile colitis in hamsters with a lipopeptide antibiotic, LY146032
- PMID: 2821892
- PMCID: PMC174884
- DOI: 10.1128/AAC.31.7.1135
Treatment of Clostridium difficile colitis in hamsters with a lipopeptide antibiotic, LY146032
Abstract
LY146032, an acidic lipopeptide antibiotic which inhibits the biosynthesis of cell wall peptidoglycan, was found to be effective in delaying death in a hamster model of pseudomembranous colitis. A dose of 0.05 mg/day was effective. The equivalent protection with vancomycin required a dose 100-fold higher, i.e., 5 mg/day.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
